IM Screen (Monospot)

Special Precautions/Comments:

Additional Information:

Infectious Mononucleosis Please note:
A negative result in a patient with appropriate clinical signs of IM may indicate that insufficient antibody has developed. Repeat samples should be sent at a later date (7-10 days) to allow the heterophile antibodies to increase to a level that can be detected.

Heterophile antibodies have been present in other disease states eg: leukaemia, RA, Burkitts lymphoma and cytomegalovirus infections.

Heterophile antibodies may persist for several months after the patient has recovered. Therefore clinical and haematological information must be considered before confirming a repeat diagnosis of IM.Infectious Mononucleosis Please note:
A negative result in a patient with appropriate clinical signs of IM may indicate that insufficient antibody has developed. Repeat samples should be sent at a later date (7-10 days) to allow the heterophile antibodies to increase to a level that can be detected.

Heterophile antibodies have been present in other disease states eg: leukaemia, RA, Burkitts lymphoma and cytomegalovirus infections.

Heterophile antibodies may persist for several months after the patient has recovered. Therefore clinical and haematological information must be considered before confirming a repeat diagnosis of IM.Infectious Mononucleosis Please note:
A negative result in a patient with appropriate clinical signs of IM may indicate that insufficient antibody has developed. Repeat samples should be sent at a later date (7-10 days) to allow the heterophile antibodies to increase to a level that can be detected.

Heterophile antibodies have been present in other disease states eg: leukaemia, RA, Burkitts lymphoma and cytomegalovirus infections.

Heterophile antibodies may persist for several months after the patient has recovered. Therefore clinical and haematological information must be considered before confirming a repeat diagnosis of IM.Infectious Mononucleosis Please note:
A negative result in a patient with appropriate clinical signs of IM may indicate that insufficient antibody has developed. Repeat samples should be sent at a later date (7-10 days) to allow the heterophile antibodies to increase to a level that can be detected.

Heterophile antibodies have been present in other disease states eg: leukaemia, RA, Burkitts lymphoma and cytomegalovirus infections.

Heterophile antibodies may persist for several months after the patient has recovered. Therefore clinical and haematological information must be considered before confirming a repeat diagnosis of IM.